“We’re not doing 30 bets a year”: Vijay Pande on betting small after leaving a16z to start VZVC

Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a "discovery" science to an "engineering" one,...